Better vision test enables precise detection of eye disorders in toddlers
The development of a new tool for testing the eyesight of children under three could mean more children receive treatment for vision difficulties earlier, leading to positive effects on learning and development.
Scientists create artificial retina phantom to standardize eye disease diagnosis equipment
The Korea Research Institute of Standards and Science (KRISS) has developed a retina-mimicking eye phantom that faithfully replicates the structural layers and microvascular network of the human retina. This innovation provides a new reference for objectively evaluating and calibrating ophthalmic imaging devices, paving the way for more accurate and reliable diagnosis of retinal diseases.
LASIK armed with 3D eye model provides better vision correction
An advanced form of LASIK (Laser-Assisted In-Situ Keratomileusis) eye surgery that uses a virtual 3D model of a person's eye appears to offer patients better vision, a new study says.
What Is Bull’s-Eye Maculopathy?
Bull’s-eye maculopathy is an eye problem that affects the macula, the part of the retina that helps you see details clearly. It gets its name because the damage creates a ring-shaped pattern, like a bull’s-eye target, and can be caused by genetic eye diseases, certain medications, or other conditions.
Medications and Substances That May Increase Macular Degeneration Risk
Age-related macular degeneration (AMD) is an eye disease that occurs when the macula — the central part of the retina that controls sharp, straight-ahead vision — is damaged. While AMD is primarily linked to aging, genetics, and smoking, some research suggests that certain medications and habits can contribute to its development.
EyeCon 2025: The latest on treating ocular surface and cornea disease
Rahul Tonk, MD, MBA a cornea, cataract, and refractive surgeon from Princeton Eye Group and faculty at Wills Eye Hospital, shared insights on recent advancements in ocular surface disease (OSD) for the EyeCon 2025 conference in Hollywood, Florida. Tonk and Joseph Allen, OD, FAAO, Dipl ABO, gave their talk "Tour of the Eye -- Stop 1: Treating Ocular Surface/Cornea Disease" during the conference, which ran from September 26-27.
The #1 Step to Preserve Your Vision With Macular Degeneration
Age-related macular degeneration (AMD) can cause central vision loss but not complete blindness. Early diagnosis through regular eye exams can slow the progression of AMD.
A soft micron accuracy robot design and clinical validation for retinal surgery
Retinal surgery is one of the most delicate and complex operations, which is close to or even beyond the physiological limitation of the human hand. Robots have demonstrated the ability to filter hand tremors and motion scaling which has a promising output in microsurgery. Here, we present a novel soft micron accuracy robot (SMAR) for retinal surgery and achieve a more precise and safer operation.
PERSPECTIVE Trial Launches in Europe
The PERSPECTIVE trial has commenced in Europe to evaluate the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT) in pseudophakic patients with late-stage age-related macular degeneration (AMD). Conducted across France, Germany, and Italy, the multicenter, randomized study aims to assess safety, visual outcomes, and rehabilitation strategies in this previously underserved patient group. The trial's findings may support future label expansion, potentially broadening access to the SING IMT in CE-referenced countries.
FDA Clears Gene Therapy Trial for GA
The FDA has approved the initiation of the Opti-GAIN phase 1/2 clinical trial for CTx001, an adeno-associated virus (AAV)-based gene therapy targeting geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Developed by Complement Therapeutics, CTx001 delivers a truncated version of complement receptor 1 (mini-CR1) to modulate both the classical and alternative complement pathways. The trial aims to evaluate the safety, tolerability, and preliminary efficacy of this novel therapy.